Covid: Virus is here to stay, experts say - other infectious disease threats to the UK - Verve Times

Covid: Virus is here to stay, experts say – other infectious disease threats to the UK – Verve Times

Leading scientists and researchers debated whether there were any infectious disease threats that could occur in the future and the things we learned from Covid, after some criticized parts of the world for not reacting quickly enough to the pandemic. The discussion with Professor Denning and Almond comes just days after it was announced that there had been a total of 183 cases of monkeypox in England. Although research by Novacyt found that 94 percent of Britons surveyed agreed that it is important to test for Covid before seeing people at risk and 90 percent think it is important before going to hospital, how have those attitudes changed recently and how likely it is that. Will Covid strike again?

When asked about the current situation of Covid in the UK, Prof Denning gave an insightful and honest answer: “The numbers have clearly fallen and the Omicron variant has replaced the Delta variant so it’s less risky. It’s still important, but less severe.”

“We still have patients who go to the hospital, we still have patients in the intensive care unit, we still have people dying from the virus and that’s globally. So it hasn’t gone away and it’s not going away almost completely.

I think this is a virus that is here to stay. What I hope for is that with forced vaccination, which produces antibody responses, it will become less severe, and as a result Covid will be more like a cold.

“But there is a large group of people who have Covid for a long time and are affected for weeks or months after the virus, which is not standard for colds.

Read more: Arthritis hack: Research may have found a way to treat and even reverse arthritis

Therefore, I think that the outcome of this virus will continue in various different dimensions over the coming years. I just hope that another very large infection on her head which I believe poses a definite danger in the future will not catch up with her.”

With the statement that other infectious diseases could pose a ‘certain risk’ in the future, Professor Denning and Almond were asked about monkeypox and hepatitis, both of which have seen recent outbreaks in the UK.

In response, Almond responded: “As a company, we still want to be quick and first in the global response to the outbreak. If we see a flow of news or information from an organization that picks up something like human adenovirus F41 potentially linked to an outbreak of hepatitis B or smallpox monkeys.

“In both cases as recent examples, we have proceeded with developments and will have tests available for research used for each of those infections in the coming weeks.

do not miss:

“If any of these things get bigger and we as a company are told they need clinical testing, it will take longer. But we are happy to do it. And that is what we have done through Covid.”

With companies like Novacyt, which have a history of responding quickly to emerging threats and providing testing always on the alert for potential threats, do Professor Denning and Almond really believe that 58 percent of those surveyed said they were happy with their testing to prevent the need for additional restrictions that would stick to their word?

Almond responded, “Research has shown that three-quarters of people are still worried about another pandemic and there are still some who would get a test or take a mask if they were to see a vulnerable person. But overall, you see a regression in that desire and that action.”

“Especially since the free tests are over. People have short memories so I guess it depends on when those surveys are done on how people really interact. I think people will go back to the wilderness over time and relax. We’re in a country where we probably don’t appreciate exposure to And vaccination allowed us to move again.”

Given the unprecedented nature of Covid and the damage it has caused to the world, Allmond provides insight into new tests that can be used to detect not only Covid, but also other respiratory infections that may increase during the winter months. This includes influenza A and B and RSV A and B.

“Given the risk of a resurgence of other respiratory viruses, this will keep some testing going,” Almond added.

When examining the increase in respiratory infections such as influenza in Australia, as it enters the winter months, this could be an indication of what is to come for Britain and whether individuals will be more susceptible to disease this year than the last. ?

When Professor Dunning was shown, he replied: “After I had two years of social distancing and wearing masks, the amount of exposure with young children and in schools that would normally have given a certain degree of immunity decreased a lot.

“We see a lot of adults with very serious illnesses. That could be a number of illnesses like the flu or the parainfluenza or rhinoviruses. It could be all of these things. And then some individuals get a bacterial infection in addition to those as well, just to add to the misery.”

“So I think the answer is yes. It’s very likely.”

With the threat of infectious disease never ending, Professor Dunning and Almond both agree that a number of things can be learned from the Covid pandemic.

Professor Denning added: “Awareness is important. It is important not to infect other people. If you are sick do not go to work. In the old days, if you did not come to work because of the cold, you were considered rather weak. But now it is important not to go into In working with the cold.”

Novacyt is developing rapid tests that can be used when outbreaks arise. They are innovators in research and accurate diagnosis, bringing tests closer to patients where they need them most. They were the first organization to bring an approved COVID-19 PCR test to Europe. www.novacyt.com

Read the original article here

Denial of responsibility! Verve Times is an automatic aggregator of all media in the world. In each content, a hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials are to their authors. If you are the content owner and do not want us to publish your material, please contact us via email – [email protected]. Content will be deleted within 24 hours.



2022-06-05 03:45:54

Leave a Comment

Your email address will not be published. Required fields are marked *